Ergolines (pharmacology) < Ergolines (therapeutic use) < Ergometry

Facettes :

List of bibliographic references indexed by Ergolines (therapeutic use)

Number of relevant bibliographic references: 27.
[0-20] [0 - 20][0 - 27][20-26][20-40]

Ident.	Authors (with country if any)	Title
002584 (2008)	Kazuo Yamashiro [Japon] ; Miki Komine-Kobayashi [Japon] ; Taku Hatano [Japon] ; Takao Urabe [Japon] ; Hideki Mochizuki [Japon] ; Nobutaka Hattori [Japon] ; Yoshitaka Iwama [Japon] ; Hiroyuki Daida [Japon] ; Michi Sakai [Japon] ; Takeo Nakayama [Japon] ; Yoshikuni Mizuno [Japon]	The frequency of cardiac valvular regurgitation in Parkinson's disease
002870 (2008)	Janine Möbes [Allemagne] ; Gregor Joppich [Allemagne] ; Frank Stiebritz [Allemagne] ; Reinhard Dengler [Allemagne] ; Christine Schröder [Allemagne]	Emotional speech in Parkinson's disease
002B03 (2007)	Susann Junghanns [Allemagne] ; Joerg T. Fuhrmann [Allemagne] ; Gregor Simonis [Allemagne] ; Christian Oelwein [Allemagne] ; Rainer Koch [Allemagne] ; Ruth H. Strasser [Allemagne] ; Heinz Reichmann [Allemagne] ; Alexander Storch [Allemagne]	Valvular heart disease in Parkinson's disease patients treated with dopamine agonists: A reader‐blinded monocenter echocardiography study
002D48 (2007)	Gregor Simonis [Allemagne] ; Joerg T. Fuhrmann [Allemagne] ; Ruth H. Strasser [Allemagne]	Meta‐analysis of heart valve abnormalities in Parkinson's disease patients treated with dopamine agonists
002E65 (2007)	Günther Deuschl [Allemagne] ; Antanas Vaitkus [Lituanie] ; Gabriele-Cornelia Fox ; Torsten Roscher ; Dieter Schremmer [Allemagne] ; Ariel Gordin	Efficacy and tolerability of entacapone versus cabergoline in parkinsonian patients suffering from wearing‐off
002F76 (2007)	Claudia Trenkwalder [Allemagne] ; Heike Benes [Allemagne] ; Ludger Grote [Suède] ; Svenja Happe [Allemagne] ; Birgit Högl [Autriche] ; Johannes Mathis [Suisse] ; Gerda M. Saletu-Zyhlarz [Autriche] ; Ralf Kohnen [Allemagne]	Cabergoline compared to levodopa in the treatment of patients with severe restless legs syndrome: Results from a multi‐center, randomized, active controlled trial
003262 (2006)	Dilek Evyapan Akkus [Turquie] ; Azize Banu Diramali [Turquie]	Postischemic delayed Holmes' tremor responding to low‐dose cabergoline
003742 (2005)	Katherine L. Widnell [États-Unis] ; Cynthia Comella [États-Unis]	Role of COMT inhibitors and dopamine agonists in the treatment of motor fluctuations
003924 (2005)	Christopher G. Goetz [États-Unis] ; Werner Poewe [Autriche] ; Olivier Rascol [France] ; Cristina Sampaio [Portugal]	Evidence‐based medical review update: Pharmacological and surgical treatments of Parkinson's disease: 2001 to 2004
003A79 (2004)	Yvonne Körner [Allemagne] ; Charlotte Meindorfner [Allemagne] ; Jens Carsten Möller [Allemagne] ; Karin Stiasny-Kolster [Allemagne] ; Doris Haja [Allemagne] ; Werner Cassel [Allemagne] ; Wolfgang Hermann Oertel [Allemagne] ; Hans-Peter Krüger [Allemagne]	Predictors of sudden onset of sleep in Parkinson's disease
003B32 (2004)	Judit Horvath [Suisse] ; Robin D. Fross [États-Unis] ; Galit Kleiner-Fisman [Canada] ; René Lerch [Suisse] ; Hans Stalder [Suisse] ; Suzanne Liaudat [Suisse] ; William J. Raskoff [États-Unis] ; Keith D. Flachsbart [États-Unis] ; Harry Rakowski [Canada] ; Jean-Claude Pache [Suisse] ; Pierre R. Burkhard [Suisse] ; Anthony E. Lang [Canada]	Severe multivalvular heart disease: A new complication of the ergot derivative dopamine agonists
003B68 (2004)	Connie Marras [Canada]	Re: Cabergoline versus levodopa monotherapy: A decision analysis
003D89 (2004)	Keith Wheatley [Royaume-Uni] ; Carl E. Clarke [Royaume-Uni] ; Natalie Ives [Royaume-Uni] ; Richard Gray [Royaume-Uni]	Cabergoline versus levodopa monotherapy
004155 (2003)	Nancy Bélanger [Canada] ; Laurent Grégoire [Canada] ; Abdallah Hadj Tahar [Canada] ; Paul J. Bédard [Canada]	Chronic treatment with small doses of cabergoline prevents dopa‐induced dyskinesias in parkinsonian monkeys
004165 (2003)	Antje M. Smala [Allemagne] ; E. Annika Spottke [Allemagne] ; Olaf Machat [Allemagne] ; Uwe Siebert [États-Unis] ; Dieter Meyer [Allemagne] ; Rudolf Köhne-Volland [Allemagne] ; Martin Reuther [Allemagne] ; Janeen Duchane [États-Unis] ; Wolfgang H. Oertel [Allemagne] ; Karin B. Berger [Allemagne] ; Richard C. Dodel [Allemagne]	Cabergoline versus levodopa monotherapy: A decision analysis
004382 (2002)	Hans Brunner [Allemagne] ; Thomas C. Wetter [Allemagne] ; Birgit Hogl [Allemagne] ; Alexander Yassouridis [Allemagne] ; Claudia Trenkwalder [Allemagne] ; Elisabeth Friess [Allemagne]	Microstructure of the non‐rapid eye movement sleep electroencephalogram in patients with newly diagnosed Parkinson's disease: Effects of dopaminergic treatment
004524 (2002)		DA agonists ‐ Ergot derivaties: Cabergoline
004525 (2002)		DA agonists ‐ Ergot derivaties: Bromocriptine
004C17 (1999)	Jean Louis Montastruc [France] ; Olivier Rascol [France] ; Jean-Michel Senard [France]	Treatment of Parkinson's disease should begin with a dopamine agonist
005649 (1996)	J. A. Simons [États-Unis]	Fluoxetine in Parkinson's disease
005660 (1996)	L. Verhagen Metman [États-Unis] ; P. J. Blanchet [États-Unis] ; D. De Jong [États-Unis] ; M. M. Mouradian [États-Unis] ; Chase [États-Unis]	Effect of the putative dopamine D1 agonist and D2 antagonist FCE 23884 on Parkinson's disease

---

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/Main/Exploration

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/KwdEn.i -k "Ergolines (therapeutic use)" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/KwdEn.i  \
                -Sk "Ergolines (therapeutic use)" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Santé
   |area=    MovDisordV3
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    KwdEn.i
   |clé=    Ergolines (therapeutic use)
}}

---

This area was generated with Dilib version V0.6.23. Data generation: Sun Jul 3 12:29:32 2016. Site generation: Wed Feb 14 10:52:30 2024